ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $126,252 | -57.8% | 350,700 | -29.7% | 0.11% | -70.6% |
| Q3 2022 | $299,000 | -33.0% | 499,045 | -44.6% | 0.38% | +24.4% |
| Q2 2022 | $446,000 | -46.8% | 900,000 | -3.5% | 0.30% | +142.4% |
| Q1 2022 | $839,000 | -16.8% | 932,399 | +3.6% | 0.12% | -15.0% |
| Q4 2021 | $1,008,000 | -17.7% | 899,850 | +30.7% | 0.15% | -11.4% |
| Q3 2021 | $1,225,000 | -51.5% | 688,400 | -10.0% | 0.17% | -53.4% |
| Q2 2021 | $2,525,000 | -7.8% | 765,276 | -6.3% | 0.36% | -33.2% |
| Q1 2021 | $2,738,000 | – | 817,165 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |